Such an imbalance might be considered a limitation of a small study such as COIN-B; however, the main reason for the imbalance between groups was discovered after the change in the population of interest from all patients with advanced colorectal cancer to those who had KRAS wild-type tumours. The gene discussed is KRAS; the disease is colorectal cancer.